MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

Phase 1
Recruiting
Conditions
Obesity
Overweight
Interventions
Drug: NNC0487-0111 (formulation D)
Drug: NNC0487-0111 (formulation C)
First Posted Date
2024-06-27
Last Posted Date
2024-07-03
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
120
Registration Number
NCT06478563
Locations
🇺🇸

Celerion, Lincoln, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath